Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Neurocrine Biosciences Inc. (NBIX)

71.34 -1.67 (-2.29%)

12-14 16:00

Open:

72.43

Pre. Close:

73.01

High:

75.28

Low:

71.02

Volume:

1,309,217

Market Cap:

6469M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

75.393 - 75.92

75.92 - 76.324

Low:

69.687 - 70.378

70.378 - 70.908

Close:

70.389 - 71.32

71.32 - 72.034

Technical analysis  (as of: 2018-12-14 4:26:16 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 108.28     One year: 128.48

Support:

Support1: 64.72    Support2: 53.85

Resistance:

Resistance1: 92.70    Resistance2: 110.00

Pivot:

84.64

Moving Averages:

MA(5): 77.95     MA(20): 85.87

MA(100): 108.40     MA(250): 96.04

MACD:

MACD(12,26): -6.85     Signal(12,26,9): -5.83

%K %D:

%K(14,3): 29.08     %D(3): 32.21

RSI:

RSI(14): 26.38

52-Week:

High: 126.98  Low: 64.72  Change(%): 1.2

Average Vol(K):

3-Month: 111659  10-Days 216914

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
NBIX has closed below the lower band by 2.7%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 53.7% wider than normal. The large width of the bands suggest high volatility as compared to NBIX's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

2018-12-13T07:59:31-05:00
Neurocrine Hit Hard As T-Force GOLD Turns To Lead

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

90.68

Shares Float (M)

88.61

% Held by Insiders

2.30

% Held by Institutions

169.80

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

0.050

EPS Est. Current Year

-2.450

EPS Est. Next Year

-1.700

EPS Est. Next Quarter

-0.410

Forward EPS

1.830

Book Value (p.s.)

17.620

PEG Ratio

Profit Margin

2.40

Operating Margin

8.34

Return on Assets (ttm)

1.2

Return on Equity (ttm)

2.5

Qtrly Rev. Growth

149.7

Gross Profit (p.s.)

1.034

Sales Per Share

EBITDA (p.s.)

0.166

Qtrly Earnings Growth

Operating Cash Flow (M)

91.48

Levered Free Cash Flow (M)

54.82

Valuation

P/E

1426.80

P/E Growth Ratio

-0.02

P/BV

4.05

P/S

1400240384.00

P/CF

70.72

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

1995-12-29

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.